Home
Conditions
Squamous Cell Carcinoma

Clinical trial condition

Squamous Cell Carcinoma

Explore clinical trials studying Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

172 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Squamous Cell Carcinoma trial results

Active, not recruiting

Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)

NCT04808999

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Active, not recruiting

Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment

NCT07697287

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +20 more
Locations: Juravinski Cancer Centre Hamilton, Ontario, Canada

View Trial Details

Active, not recruiting

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

NCT03952585

Conditions: Basaloid Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

View all 494 locations

View Trial Details

Active, not recruiting

Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

NCT05070403

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +8 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, not recruiting

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

NCT05681039

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

NCT05048459

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Active, not recruiting

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

NCT05574101

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +14 more
Locations: University of Colorado (Data Collection Only) Aurora, Colorado, United States

Moffitt Cancer Center (Data Collection Only) Tampa, Florida, United States

Memorial Sloan Kettering Cancer Center at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

View all 13 locations

View Trial Details

Active, not recruiting

1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

NCT04150900

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
Locations: University of Maryland Medical Center Baltimore, Maryland, United States

View Trial Details

Active, not recruiting

A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

NCT06041802

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
Locations: Nagoya University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan

Sapporo Medical University Hospital ( Site 0002) Sapporo, Hokkaido, Japan

Yokohama City University Hospital ( Site 0016) Yokohama, Kanagawa, Japan

Tohoku University Hospital ( Site 0019) Sendai, Miyagi, Japan

View all 18 locations

View Trial Details

Active, not recruiting

Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.

NCT05858229

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
Locations: Rochester Dermatologic Surgery Victor, New York, United States

View Trial Details

Squamous Cell Carcinoma

Squamous Cell Carcinoma trial results

Related conditions